KOLINPHARMA® has obtained the recognition of “Growth Leader 2025" for the sixth consecutive year
This year, too, Kolinpharma® was confirmed among the 500 Italian companies that stood out for the highest revenue growth in the 2020-2023 observation period, with a revenue CAGR of 24.02%, up 8 percentage points on the previous three-year observation period.
This is a list of the 500 Italian companies with the highest revenue growth in the three-year period 2020-2023 that took part in the call launched by Il Sole 24 Ore and Statista
The criteria considered:
Revenue of at least €100,000 in 2020
Revenue of at least €1.5 million in 2023
Being an independent Italian company
Meeting the principles of good repute
Nearly 1,000 companies applied. The data was checked by Statista
Another important milestone on KOLINPHARMA's successful journey!

















